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Abstract objective To understand reasons for suboptimal and delayed uptake of antiretroviral therapy (ART)
by describing the patterns of HIV testing and counselling (HTC) and outcomes of ART eligibility
assessments in primary clinic attendees.
methods All clinic attendances and episodes of HTC were recorded at two clinics in Blantyre. A
cohort of newly diagnosed HIV-positive adults (>15 years) was recruited and exit interviews under-
taken. Logistic regression models were constructed to investigate factors associated with referral to start
ART. Qualitative interviews were conducted with providers and patients.
results There were 2398 episodes of HTC during 18 021 clinic attendances (13.3%) between January
and April 2011. The proportion of clinic attendees undergoing HTC was lowest in non-pregnant women
(6.3%) and men (8.5%), compared with pregnant women (47.2%). Men had more advanced HIV
infection than women (79.7%WHO stage 3 or 4 vs. 56.4%). Problems with WHO staging and access to
CD4 counts affected ART eligibility assessments; only 48% completed ART eligibility assessment, and
54% of those reporting WHO stage 3 ⁄4 illnesses were not referred to start ART promptly. On multi-
variate analysis, HIV-positive pregnant women were significantly less likely to be referred directly for
ART initiation (adjusted OR: 0.29, 95% CI: 0.13–0.63).
conclusions These data show that provider-initiated testing and counselling (PITC) has not yet been
fully implemented at primary care clinics. Suboptimal ART eligibility assessments and referral (reflecting
the difficulties of WHO staging in primary care) mean that simplified eligibility assessment tools are
required to reduce unnecessary delay and attrition in the pre-ART period. Simplified initiation criteria
for pregnant women, as being introduced in Malawi, should improve linkage to ART.
keywords HIV, provider initiated testing and counselling, WHO clinical staging, antiretroviral therapy,
programmatic evaluation, primary health care, qualitative
Introduction
By 2010, over 5 million HIV-infected individuals were
receiving antiretroviral therapy (ART) in low and middle
income countries (UNAIDS 2010), with rapid scale-up
achieved in a number of sub-Saharan African coun-
tries_ENREF_2 (Vitoria et al. 2009). In the face of
resource and infrastructural constraints, Malawi has dem-
onstrated great success in scaling-up the national ART
programmes using a decentralized model and with task-
shifting of treatment delivery from physicians to other
cadres of health providers (Lowrance et al. 2008). By
December 2010, over 300 000 individuals had initiated
treatment (Ministry of Health of Malawi 2010).
Despite these achievements, coverage of ART remains
suboptimal both in Malawi and elsewhere. UNAIDS
estimates that in sub-Saharan Africa, only 37% of adults
in immediate need of ART (defined as having a CD4 count
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of <350 cells ⁄ll) currently receive treatment (UNAIDS
2010). In Malawi, this figure is 48% (World Health
Organization 2010). In addition, most patients do not
receive ART until they have advanced immunosuppression
(Bassett et al. 2010), increasing the risk of early ART
mortality (Lawn et al. 2008), treatment complications,
opportunistic infections and transmission of HIV to
partners (Granich et al. 2009).
Provider-initiated HIV testing and counselling (PITC) is
the main entry point to comprehensive HIV care (including
ART) for individuals attending health facilities (World
Health Organization 2007a). Compared with client-
initiated HIV voluntary testing and counselling (VCT),
PITC has been shown to be highly cost-effective (Walensky
et al. 2011). Malawian National HIV care guidelines
recommend that all individuals attending health facilities
should be offered PITC (Ministry of Health 2008), but
scale-up of this approach has been held back by human
resources and infrastructure constraints.
One of the critical barriers to ART scale-up in public
health programmes has been the low proportion of newly
diagnosed HIV-positive individuals who successfully initi-
ate ART or are retained in pre-ART care if they are not yet
eligible (Tayler-Smith et al. 2010). Current estimates are
that only one-third of newly diagnosed HIV-positive adults
are retained in care and go on to initiate ART (Rosen &
Fox 2011).
This study investigated HIV testing, ART eligibility
assessment and subsequent referral for ART at two large
primary health care clinics offering PITC and comprehen-
sive HIV care in Blantyre, Malawi. The objectives were to
describe the proportion of primary clinic attendees receiv-
ing HIV testing and counselling (HTC); to describe referral
patterns following HIV diagnosis and investigate patient
and provider factors associated with decisions to refer; and
to identify current limitations in the health system that
contribute to delayed initiation of ART.
Methods
Study Design
A prospective cohort study of adults attending primary
health care clinics and undergoing HTC in Blantyre,
Malawi was undertaken. Baseline data from clinic atten-
dance records between January and April 2011 are
presented. Cohort follow-up is ongoing.
Study site
Two primary health care centres (Ndirande Health Centre
and Chilomoni Health Centre) with a combined catchment
population of about 168 000 adults were selected as study
sites in the high-density residential areas of Blantyre. These
are the major primary care providers of ART treatment,
with 3637 and 2083 patients, respectively, receiving ART
at the start of the study (Ministry of Health of Malawi
2010). Adult HIV prevalence in urban north Blantyre was
approximately 18.5% (Choko et al. 2011).
ART care pathway in Malawi
Malawian national HIV care guidelines recommend that,
following confirmation of HIV infection, patients undergo
clinical staging based on the World Health Organization’s
Clinical Staging System for HIV ⁄AIDS (World Health
Organization 2005, 2007b). Those in WHO stage 3 or 4 or
with a CD4 count of <250 cells ⁄ll are ‘ART eligible’ and
should be referred directly for treatment education and
ART initiation – Figure 1. Individuals in WHO stage 1 or 2
should be referred for venipuncture for CD4 count (in this
population, at the nearby tertiary Queen Elizabeth Central
Hospital). Patients then collect their CD4 count result and
bring them to the primary health care centre for review.
Those with a CD4 count of <250 cells ⁄ll are ‘ART eligible’
and referred for treatment education and ART initiation at
the same primary care clinic; those with a CD4 count of
‡250 cells ⁄ll are ‘not ART eligible’ and should be ‘referred
to the general health services for management and advice,
for example, initiation of cotrimoxazole preventative
therapy’ (Ministry of Health 2008).
At the time of the study, ART eligibility criteria for
pregnant women were the same as for non-pregnant adults.
Pregnant women not meeting these criteria were referred
for prevention of mother to child therapy (PMTCT).
Study participants and case definitions
Data on all clinic attendances and HIV testing events were
extracted by research assistants from clinic registers. At
each of the two clinics, newly diagnosed HIV-positive
adults (‡16 years) were asked to participate in the study,
with informed consent. Participants were interviewed
immediately after completion of all HIV testing procedures
and WHO staging (if completed). As result of the large
number of clinic attendees and limited availability of
private rooms, the maximum number of participants
recruited per day was limited to six per clinic.
Participants underwent a baseline interview including
questions on demographic and socioeconomic variables,
previous HIV tests, knowledge and awareness of HIV and
ART treatment, and their understanding of instructions
given to them by the clinic staff regarding follow-up and
referral appointments. Participants were then indepen-
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dently staged by study research assistants using the WHO
clinical staging criteria (World Health Organization 2005).
Participants referred to treatment education prior to
initiation of ART were classified as ‘referred directly for
ART’. Participants referred for CD4 count measurement
were classified as ‘referred for further ART assessment’.
The participant’s understanding of instructions was con-
firmed by inspection of patient-carried health records and
HIV testing registers. Where research staff identified poor
understanding or misinterpretation, patients were referred
back to clinical staff for clarification.
HIV testing procedures
Routine HIV testing algorithms followed national guide-
lines (serial testing using Determine 1 ⁄2, Abbott, Tokyo,
Japan, and, if positive, Uni-Gold HIV, Trinity Biotech,
Dublin, Ireland, with SD Bioline 1 ⁄2, Standard Diagnos-
tics, Korea if the first two were discordant).
Statistical methods
Participant demographic and clinical characteristics were
expressed as proportions, medians or means as appropriate
and compared using chi square tests and Wilcoxon rank
sum tests. Self-reported general health was recorded on a
4-item Likert-type scale (excellent, good, fair or poor).
Referral for onward care following positive HIV diagnosis
was expressed as a dichotomous variable (referral for
‘ART’ or ‘referral for further assessment’) and logistic
regression models constructed to examine associations
between participant characteristics and referral outcomes.
Factors associated with incorrect referral (as assessed
against study-performed WHO clinical staging) were
examined using univariate logistic regression. Statistical
analysis was undertaken using STATA v11.2 (Statacorp,
College Station, TX, USA).
Qualitative in-depth interviews
Study participants were purposively sampled to include a
mix of men, pregnant and non-pregnant women and
participants recruited from both study clinics. Health
workers at the two clinics were purposively sampled to
include those whose roles predominantly involved offering
and performing HTC (counsellors) and those who pre-
dominantly undertook ART eligibility assessments and
made referrals (clinicians), although there was some
overlap in roles.
A trained qualitative research fieldworker undertook in-
depth interviews based on semi-structured interview guide
with participants and health workers. Interviews were
Stage 3 or 4 
HIV testing 
Given HIV-
positive result 
WHO staging by 
health worker 
Not ART eligible ART eligible 
Referral for ART 
education and
initiation 
Complete ART 
education 
Initiate ART 
Refer for CD4 
count by health 
worker*
Blood taken for 
CD4 count 
Collect CD4 results 
Discuss CD4 
results with
clinician 
Identify treatment 
guardian 
Stage 1 or 2 
<250 cells/µl >250 cells/µl 
Figure 1 Antiretroviral therapy (ART)
care pathway in Malawian National
Programme. *After first occasion, WHO
staging and CD4 are repeated 6-monthly
for those not ART eligible.
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audio recorded in Chichewa, translated into the English
language and transcribed. A sample of 5% of transcripts
was back-translated into Chichewa to check consistency.
Coding of data was performed using NVIVO 9 (QSR,
Melbourne, Australia). Analysis of themes used a frame-
work approach.
Ethical approval
Ethical approval was received from the Research Ethics
committees of Liverpool School of Tropical Medicine and
the College of Medicine of Malawi. Participants recruited
to the study give informed written (or witnessed thumb-
print) consent. Permission was obtained from the Blantyre
District Health Officer and Nurses in Charge of both
clinics for anonymized data collection from clinic
registers.
Results
Clinic attendances during study period
A total of 18 021 adults (16 years or older) attended the
two study clinics between January and April 2011
(Table 1). Clinic attendance was much more common by
women [12 424 ⁄18 021 (68.9%)] than men [5597 ⁄18 021
(31.1%)]. This pattern remained after excluding atten-
dances made by pregnant women [non-pregnant women-
visits: 9625 ⁄15 222 (63.2%), male-visits: 5597 ⁄15 222
(36.8%)]. Ndirande Health Centre (located next to a busy
urban market area) was busier than Chilomoni Health
(located in a residential area).
HIV testing and counselling during clinic attendances
HIV testing and counselling was completed on 2398 of
18 021 (13.3%) clinic attendances (Figure 2). The highest
rate of HTC was seen among pregnant women (1320 ⁄2799
attendances, 47.2%), but was substantially lower among
men (474 ⁄5597 attendances, 8.5%) and non-pregnant
women (604 ⁄9625 attendances, 6.3%). Individuals
attending Chilomoni were significantly more likely to
receive HTC than at Ndirande (18.5% vs.10.5%,
P < 0.001 – Figure 2). A higher proportion of male
attendees at Chilomoni underwent HTC compared with
Ndirande (13.0% vs. 6.0%. P < 0.001).
HIV testing outcomes
A total of 444 (18.5%) of 2398 attendees tested were HIV-
positive. HIV prevalence was 19.2% (208 ⁄1175) in Ndi-
rande compared with 17.7% (235 ⁄1223) in Chilomoni
(P = 0.340). HIV prevalence was lowest in pregnant
women (15.1%), followed by men (20.9%) and non-
pregnant women (24.2%), P < 0.001: this may reflect
higher rates of testing among pregnant attendees. HIV
prevalence was significantly higher in men tested at
Ndirande (55 ⁄216 [25.5%]) than at Chilomoni [44 ⁄258
(17.0%), P = 0.025].
Baseline characteristics of participant recruited to cohort
study
A total of 280 participants (76.9% of those eligible)
were recruited to the study (Figure 2). Of the 164
individuals who were not recruited, 80 were not
eligible, because six participants had already been
recruited from the clinic on that day, and 84 patients did
not consent to participation. Characteristics of partici-
pants closely reflected HIV-positive attendees. Forty-three
per cent of participants were pregnant women, 25%
were men and 32% were non-pregnant women; similar
to the total population of clinic attendees testing HIV-
positive.
Baseline characteristics of the 280 cohort study partic-
ipants are shown in Table 2. There were high levels of
illiteracy (18.9%) and high reported household food
insecurity (20.7%). 85.5% men were in formal employ-
ment, but this was much lower in women (30.3%). Just
over half (53.9%) of study participants had had a
previous HIV test and 6 (2.1%) were currently being
treated for TB. Men (71.0%) were significantly more
Table 1 Clinic attendances during study period
Chilomoni Health Centre 6348 Ndirande Health Centre 11 673
Women 4357 Men 1991 Women 8067 Men 3606
General outpatients department 2967 68.1% 1718 86.3% 6028 74.7% 3364 93.3%
TB clinic 13 0.3% 15 0.8% 13 0.2% 26 0.7%
Antenatal clinic 460 10.6% n ⁄ a n ⁄ a 1019 12.6% n ⁄ a n ⁄ a
HIV testing and counselling clinic 917 21.1% 258 13.0% 1007 12.5% 216 6.0%
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likely to have undergone HTC for the first time than
women (48.3%, P = 0.001). They also had worse
self-reported general health: 66.7% self-reported their
general health to be ‘fair’ or ‘poor’ compared with
36.0% of women (P < 0.001). On study assessed WHO
staging, men had more advanced illness than women,
with 79.7% of men in Stage 3 or 4, compared with
56.4% of women (P = 0.001).
Awareness and readiness for ART
Participants had high awareness of HIV ⁄AIDS, with nearly
half (128 ⁄280, 45.7%) knowing at least one family or
household member who had been diagnosed HIV-positive.
Similarly, 31.4% (88 ⁄280) knew of at least one family
member who had taken ART, and 28.2% (79 ⁄280) knew
at least one family or household member who had died of
Clinic attendances = 18 021 
Men = 5597 (31.1%) 
Pregnant women = 2799 (15.5%) 
Non-pregnant women = 9625 (53.4%)
Underwent HTC = 2398 (13.3%) 
Men = 474 (8.5%) 
Pregnant women = 1320 (47.2%) 
Non-pregnant women = 604 (6.3%)
HIV-positive = 444 (18.5%) 
Men = 99 (20.9%) 
Pregnant women = 199 (15.1%) 
Non-pregnant women = 146 (24.2%)
HIV-negative = 1954 (81.5%) 
Men = 375 (79.1%) 
Pregnant women = 1121 (84.9%) 
Non-pregnant women = 458 (75.8%)
Referred for 
ART = 28 
Men = 7  
PW = 16  
NPW = 5  
Not recruited to study = 164 
Not eligible = 80 
(>6 attendances/clinic/day = 80) 
Declined to participate = 84 
Unable to recall
clear
instructions = 9 
Men = 2 
PW = 5 
NPW = 2 
Recruited to cohort study = 280
Men = 69 
Pregnant women = 121 
Non-pregnant women = 90 
Study research assistant assessment 
(WHO stage 3/4) = 174
Men = 55 
Pregnant women = 45 
Non-pregnant women = 74 
Study research assistant assessment 
(WHO stage 1/2) = 106
Men = 14 
Pregnant women = 76 
Non-pregnant women = 16 
Referred for 
further 
assessment = 69
Men = 5  
PW = 55  
NPW = 9 
Referred for 
ART = 80 
Men = 32  
PW = 8 
NPW = 40  
Referred for 
further 
assessment = 84 
Men = 22 
PW = 33  
NPW = 29 
Unable to  
recall clear
instructions = 10 
Men = 1 
PW = 4  
NPW = 5 
Figure 2 Clinic attendances, HIV test uptake and patterns of referral in participants recruited to cohort study. PW, pregnant women;
NPW, non-pregnant women.
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HIV ⁄AIDS. Readiness to take ART was high, with 98.5%
(267 ⁄271) agreeing that they would take ART if referred
by a health worker, and 87.1% (243 ⁄279) agreeing that
they felt ready to start taking ART.
Referral for ART and HIV care
Following confirmed HIV diagnosis, 108 participants
(38.6%) were directly referred for ART by clinic staff, 153
(54.6%) were referred for further ART eligibility assess-
Table 2 Baseline characteristic of HIV-positive clinic attendees recruited to cohort study
Women (n = 211) Men (n = 69) P-value
Pregnant (ANC clinic) 121 57.3% n ⁄ a n ⁄ a –
Age (years), median (IQR) 27 23–31 33 29–39 0.001
BMI (kg ⁄m2) median (IQR) 23 20–24 21 19–22 0.001
Literacy
Illiterate 48 22.7% 5 7.2% 0.004
Currently in formal employment
Yes 64 30.3% 59 85.5% <0.001
Self-reported general health
Excellent 61 28.9% 8 11.6% <0.001
Good 74 35.1% 15 21.7%
Fair 61 28.9% 29 42.0%
Poor 15 7.1% 17 24.6%
WHO stage
Stage 1 or 2 92 43.6% 14 20.3% 0.001
Stage 3 or 4 119 56.4% 55 79.7%
Reports household food insecurity
Yes 43 20.4% 15 21.7% 0.809
First time tested for HIV
Yes 109 51.7% 20 29.0% 0.001
Perceived difficulty in attending primary health care clinic
Not difficult 23 11.1% 13 18.8% 0.096
Difficult 185 88.9% 56 81.2%
How many family or household members do you know to be HIV-positive?
None 120 56.9% 32 46.4% 0.129
One or more 91 43.1% 37 53.6%
How many family or household members do you know who have ever taken ART?
None 148 70.1% 44 63.8% 0.322
One or more 63 29.9% 25 36.2%
How many family or household members do you know to have died from HIV ⁄AIDS?
None 153 72.5% 48 69.6% 0.637
One or more 58 27.5% 21 30.4%
If I was told I needed to take ART, I would be happy to take it
Agree 199 98.0% 68 100.0% 0.507
Disagree 2 1.0% 0 0.0%
BMI, body mass index.
WHO staging assessment as performed by study research assistant.
Defined as skipping a meal in the last 2-weeks to ensure food.
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ment (CD4 count) and 19 (6.8%) reported having received
no clear instructions. Only 134 (48.2%) had undergone
WHO clinical staging at the time of their HIV test, with the
remainder asked to return by clinic staff for staging when
clinicians were available.
Of the 174 participants in WHO stage 3 or 4, 80
(46.0%) were referred directly for ART by clinic staff with
the remaining 54.0% referred instead for CD4 count
measurement. Three quarters (78 ⁄106, 73.6%) of partic-
ipants in WHO stage 1 or 2 were correctly referred for
CD4 count measurement. On univariate logistic regression,
participants diagnosed at Ndirande were less likely to be
incorrectly referred than those at Chilomoni [odds ratio
(OR): 0.60, 95% confidence interval (CI): 0.37–0.97].
However, the gender, age and pregnancy status of partic-
ipants were not associated with incorrect referral
(Table 3).
Factors associated with direct referral for ART
On univariate analysis (Table 4), factors significantly
associated with direct referral for ART included male sex
(OR 2.6, 95% CI: 1.53–4.67), worse self-reported general
health (Ptrend < 0.001) and being in WHO Stage 3 or 4
(OR: 2.37, 95% CI: 1.40–4.01). Pregnant women were
significantly less likely to be directly referred for ART (OR
0.22, 95% CI: 0.13–0.38).
On multivariate adjustment, self-reported ‘poor’
(adjusted OR: 4.21, 95% CI: 1.35–13.07) and ‘fair’
(adjusted OR: 2.62, 95% CI: 1.15–5.93) general health
remained significantly associated with direct referral for
ART, whereas pregnancy (adjusted OR: 0.38, 95% CI:
0.18–0.78) was associated with referral for further ART
assessment. WHO stage was not associated with direct
referral for ART (adjusted OR: 0.91, 95% CI: 0.46–1.79),
nor was male sex (adjusted OR: 0.97, 95% CI: 0.50–1.90).
Attendees at Ndirande were more likely to be referred
directly for ART initiation compared with those at
Chilomoni (adjusted OR: 2.82, 95% CI: 1.54–5.17).
Qualitative in-depth interviews
In total, 30 in-depth interviews were undertaken with study
participants and 10 with healthcare providers. Qualitative
analysis of clinic HIV testing practices showed that, rather
than being offered HIV testing by providers when attending
the clinic, non-pregnant participants tended to be diagnosed
after a prolonged period of declining ill health that
promoted self-presentation and request for HIV testing.
So I was examining myself and could see that my
body is not alright. That is what made me think that
aah its better to go where I hear that they do some
tests – maybe I have a disease – That is why I
mustered up boldness to go for testing.
Table 3 Univariate associations with
incorrect referral following HIV-positive
diagnosis
Proportion incorrectly
referred (%)
Odds Ratio
(95% CI) P-value
Male sex 30 ⁄ 69 (43.5) 0.99 (0.58–1.72) 0.986
Pregnancy 53 ⁄ 121 (43.0) 1.02 (0.63–1.64) 0.946
Age (continuous) – 1.00 (0.97–1.03) 0.956
BMI (kg ⁄m2 – continuous) – 0.97 (0.91–1.05) 0.553
WHO stage
Stage 1 or 2 28 ⁄ 106 (26.4) 1
Stage 3 or 4 94 ⁄ 174 (54.0) 3.27 (1.94–5.53) <0.001
Self-reported general health
Excellent 24 ⁄ 69 (34.8) 1 0.185
Good 40 ⁄ 89 (44.9) 1.96 (1.03–3.74)
Fair 46 ⁄ 90 (51.1) 1.53 (0.80–2.93)
Poor 12 ⁄ 32 (37.5) 1.12 (0.47–2.69)
Ndirande Health Centre 48 ⁄ 130 (36.9) 0.60 (0.37–0.97) 0.036
In formal employment 54 ⁄ 123 (43.9) 0.89 (0.38–2.09) 0.921
Illiterate 23 ⁄ 53 (43.4) 0.99 (0.54–1.81) 0.977
Household food insecurity 23 ⁄ 58 (39.7) 0.82 (0.45–1.47) 0.498
First time tested for HIV 64 ⁄ 151 (42.4) 0.90 (0.56–1.45) 0.665
Patient perceived difficulty
in attending clinic
20 ⁄ 36 (55.6) 0.36 (0.29–1.17) 0.125
BMI, body mass index.
Defined as skipping a meal in the last 2-weeks to ensure food for children.
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Male participant, Chilomoni Health Centre.
Provider-initiated HIV testing and counselling seemed
not to be fully implemented within the primary health care
system, and instead, HIV testing operated on a more
traditional VCT model, albeit situated in a health facility.
In contrast, when attending for antenatal care, pregnant
women understood that they would be tested for HIV.
Acceptance of this approach seemed to be high.
When I came for antenatal clinic I was told that ‘Here
we test for HIV, we test any person who is pregnant.
Female participant, pregnant, Ndirande Health Centre.
What they want is just to ask you ‘Are you ready?’ [to
test] and we answer: Yes!
Female participant, pregnant, Ndirande Health Centre.
After diagnosis of HIV, participants described switch-
ing to a ‘dependant role’. Most had heard of ART, were
aware of the potential benefits and wanted to start
treatment rapidly. However, their care-seeking became
dependent upon interactions with health workers (who
were often rushed and provided little information), their
families (from whom they had to borrow money to travel
for CD4 count measurement and had to recruit as their
‘treatment guardian’) and the health system (long queues
at health facilities, unreliable lab equipment and clini-
cians being intermittently available). As a result, many
felt frustrated with the difficulties of getting CD4
measurements and results and some dropped-out of ART
assessment.
Table 4 Univariate and multivariate asso-
ciations with direct referral for ARTOdds Ratio
(95% CI)
Adj. Odds Ratio
(95% CI) P-value
Male sex 2.68 (1.53–4.67) 0.87 (0.43–1.75) 0.697
Pregnant 0.22 (0.13–0.38) 0.29 (0.13–0.63) 0.002
Age (continuous) 1.06 (1.03–1.10) 1.03 (1.00–1.07) 0.042
BMI (kg ⁄m2 – continuous) 0.85 (0.79–0.92) 0.95 (0.86–1.04) 0.057
Illiterate 1.28 (0.77–2.04)
In formal employment 1.91 (1.17–3.11)
WHO stage
Stage 1 or 2 1 1 0.997
Stage 3 or 4 2.37 (1.40–4.01) 1.00 (0.50–2.01)
Self-reported general health
Excellent 1 1 0.036
Good 1.90 (0.91–3.96) 2.43 (0.98–5.98)
Fair 3.44 (1.68–7.05) 2.62 (1.15–5.93)
Poor 10.04 (3.81–26.45) 4.55 (1.41–14.60)
Clinic where HTC performed
Chilomoni Health Centre 1 1 0.001
Ndirande Health Centre 1.61 (0.99–2.62) 2.82 (1.54–5.17)
First time tested for HIV
Yes 1.26 (0.77–2.04)
Household food insecurity§
Yes 1.06 (0.59–1.91)
Patient perceived difficulty
in attending clinic
Difficult 0.77 (0.38–1.56)
BMI, body mass index; HTC, HIV testing and counselling
Not carried forward for multivariate analysis due to collinearity.
WHO staging assessment as performed by study research assistants.
§Defined as skipping a meal in the last 2-weeks to ensure food for children.
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So it took me time the way [Central Hospital] is –
there are a lot of people. I went there in the morning, I
happened to come back in the evening […]. When I
went there in February my file got lost.’
Female participant, pregnant, Ndirande Health Centre.
Interviews with health workers predominantly focused
on their experience of undertaking ART eligibility assess-
ment and decision-making. They were candid about the
difficulties in undertaking WHO staging, and acknowl-
edged that time constraints forced them to refer patients
for CD4 count measurement if unable to complete WHO
staging during the time available for busy clinics.
Sometimes we have more than 80 clients, so out of
that number, to do WHO staging for everybody, it
seems as if we are delaying others. So, we just tell
them in a short-cut way and refer them for CD4 count
to ensure that everybody should feel that they have
been helped in the right time.
Nurse, female, antenatal clinic, Ndirande Health Centre.
Despite these frustrations, health workers felt proud when
they saw clients regain health following ART initiation.
Discussion
The main findings from this study were the low proportion
of clinic attendees offered PITC and the impact of health
system constraints in ART eligibility assessment and
referral for HIV care. Critical bottlenecks presenting major
constraints to timely completion of ART eligibility assess-
ment were the lack of CD4 count machines on-site, and the
complexity and time taken to do the current clinical staging
(WHO staging). Taken together, these findings show that
there are significant limitations in the current provision of
PITC and access to comprehensive HIV care in the primary
health care system that could impair efforts to ensure
universal knowledge of HIV status and access to ART.
Provider-initiated HIV testing and counselling [which is
recommended by WHO for countries with generalized HIV
epidemics (World Health Organization 2007a)] differs
from client-initiated VCT, in that providers are responsible
for recommending HIV testing to all health facility
attendees, ‘even if they do not have obvious HIV-related
symptoms or signs’ (World Health Organization 2007a). In
the VCT approach, individuals who recognize themselves
to be unwell request testing. Compared with VCT, PITC
has been shown to be quicker, to result in a substantially
higher proportion of clinic attendees agreeing to test
(Braitstein et al. 2008; Harries et al. 2010; Topp et al.
2011)_ENREF_18 and to be acceptable for clients and
providers (Obermeyer & Osborn 2007).
This study found that only 13% of all adult clinic
attendees underwent HTC, with particularly low propor-
tions seen in men and non-pregnant women. This is
substantially lower than would have been expected if PITC
had been fully implemented in the health system (Topp
et al. 2011). To increase uptake of HTC among clinic
attendees, guidelines recommending PITC should be fully
put into practice, with additional commitments made to
appropriately resourcing this approach including increas-
ing availability of HTC trained health workers and
minimizing HIV test kit stock-outs. To streamline PITC,
opt-out blood sampling could be undertaken at clinic
registration, with post-test counselling provided during the
subsequent clinical consultation.
Of particular concern was the high proportion of men
who were diagnosed HIV-positive at an advanced stage of
disease (80% in WHO stage 3 or 4). Men were more likely
to be referred directly for ART initiation than women. This
suggests that the advanced degree of immunosuppression
at which men initiate ART (Braitstein et al. 2008), and
their higher early ART mortality (Lawn et al. 2008), are
resultant upon late diagnosis of HIV and possible failure of
linkage between testing and treatment (Bassett et al. 2010),
rather than health worker referral patterns. Scale-up of
strategies to encourage men to test more frequently and at
an earlier stage of illness [including full implementation of
PITC, ideally supported by workplace (Corbett et al. 2006)
and home-based testing programmes (Ganguli et al.
2009)] are urgently required.
Provider-initiated HIV testing and counselling was more
fully implemented in the antenatal clinic, with a higher
proportion of pregnant attendees undergoing HTC (47%).
In Malawi in 2010, 69% of ANC clinic attendees had their
HIV status ascertained during the course of their pregnancy
(Ministry of Health of Malawi 2010). Most pregnant
women make more than one antenatal visit during the
course of their pregnancy, and so, our figure will under-
estimate uptake of HTC.
Pregnancy was found to be significantly associated with
71% lower odds of direct referral for ART after adjusting
for other confounders that may have associated with
pregnant women’s propensity to be tested earlier in their
disease course through antenatal care. We speculate based
on the qualitative interviews with healthcare providers that
pregnant women may have been referred to PMTCT rather
than for ART initiation due to difficulties in completing
WHO clinical staging. Universal combination ART for
pregnant women, as is being implemented in Malawi
(PMTCT B+) (Schouten et al. 2011), will substantially
simplify the process of ART eligibility assessment in
pregnancy.
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ART eligibility assessment and referral following HIV
diagnosis were found to be suboptimal, despite partici-
pant’s familiarity with HIV and ART and readiness to
initiate treatment. Forty-four per cent of participants were
incorrectly referred with 54% of those in WHO stage 3 or
4 referred for CD4 count measurement instead of being
referred directly to start ART. We also noted differences in
ART referral outcomes between clinics, suggesting that
health worker and health system factors will be important
to address in improving linkage to ART. Critical stumbling
blocks identified were the difficulties and cost to clients of
obtaining CD4 count measurements and, for providers, the
complexity and length of WHO clinical staging.
The World Health Organization’s Clinical Staging Sys-
tem for HIV ⁄AIDS was revised in 2005 and has a
sensitivity of 51–52% and specificity of 68–88% in
predicting CD4 count of <200 cells ⁄mm3 (Kagaayi et al.
2007; Jaffar et al. 2008). However, it was initially designed
as a specific and low-cost means of diagnosing patients
with AIDS prior to the widespread availability of point of
care diagnostic HIV tests (Gilks 1990). Our quantitative
and qualitative data show that a simplified clinical staging
approach to ART eligibility assessment that can be utilized
in primary care may be required to ensure that patients are
managed appropriately. At the time of this study, the CD4
threshold for initiation in Malawi was <250 cells ⁄ll. Since
completion of the study, the threshold has been raised to
<350 cells ⁄ll; however, the difficulties observed in com-
pleting CD4 count measurement at primary care level will
be difficult to overcome without innovative technologies.
The anticipated scale-up of technologies such as point of
care CD4 count analysis systems may circumvent these
problems, if widely implemented (Zachariah et al. 2011).
Limitations
Despite the large numbers of clinic attendances examined,
this study was conducted over a relatively short time
period. Health system factors, such as staffing levels
and availability of HIV test kits, at the time of the study,
may have influenced findings. We did not take CD4
measurements at the time of HIV diagnosis, as the
purpose was to describe the patterns of referral under
programmatic conditions, and doing so would have been
an intervention.
Relevance of findings for improving linkage from HIV
diagnosis to ART initiation
There is increasing evidence that expanded access to ART,
and initiation at higher CD4 count thresholds will have
large public health benefits (Granich et al. 2009). This has
turned attention towards the high rates of attrition seen
between HIV diagnosis and initiation of ART, with some
studies suggesting that only between one-sixth and one-
third of patients will go on to initiate ART (Bassett et al.
2010; Rosen & Fox 2011; Topp et al. 2011). Findings
from this study go some way to explaining the underlying
reasons for poor linkage in the immediate post-diagnosis
period in Malawi and will need to be confirmed in other
high HIV prevalence settings. Considerable care will be
required to ensure that HIV testing and ART programmes
are structured to facilitate rapid and uncomplicated access
to treatment.
Conclusions
In summary, we report on low levels of PITC (especially for
men and non-pregnant women), suboptimal ART eligibil-
ity assessments and deficiencies in patterns of referral for
ART among clinic attendees in primary care (with
pregnant women particularly disadvantaged). Of particular
concern was that assessment of ART eligibly using the
WHO Clinical Staging System did not seem ideally suited
to busy primary health care clinic clinics. These findings
contribute to understanding of the poor rates of linkage
and long delays between HIV diagnosis and ART
initiation.
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